Streetbeat News

Price Targets

AMR

B. Riley Securities analyst Lucas Pipes maintains a Buy rating on Alpha Metallurgical (NYSE:AMR) and raises the price target from $199 to $254.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:53 pm

META

Guggenheim analyst Michael Morris maintains a Buy rating on Meta Platforms (NASDAQ:META) and raises the price target from $375 to $380.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:49 pm

COST

Truist Securities analyst Scot Ciccarelli has maintained a 'Buy' rating on Costco Wholesale (NASDAQ:COST) and raised the price target from $597 to $619.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:45 pm

MLKN

Craig-Hallum analyst Alex Fuhrman maintains a Hold rating on MillerKnoll (NASDAQ:MLKN) and raises the price target from $20 to $25.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:43 pm

SNX

RBC Capital analyst Ashish Sabadra has reiterated a 'Sector Perform' rating on TD Synnex (NYSE:SNX) and maintained a price target of $97.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:39 pm

NTNX

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Nutanix (NASDAQ:NTNX) and raises the price target from $43 to $47.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:35 pm

EOG

JP Morgan analyst Arun Jayaram maintains an Overweight rating on EOG Resources and raises the price target from $145 to $156.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:32 pm

ICPT

RBC Capital analyst Brian Abrahams maintains Intercept Pharma (NASDAQ:ICPT) with a Sector Perform and raises the price target from $12 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:25 pm

XPO

Evercore ISI Group has upgraded XPO Logistics' stock from In-Line to Outperform and raised its price target to $79. This has resulted in XPO shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 3:21 pm

HOOK

RBC Capital analyst Brian Abrahams has reiterated his 'Outperform' rating on HOOKIPA Pharma (NASDAQ:HOOK) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 2:59 pm